FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.9310
-0.0330 (-3.42%)
At close: Jun 12, 2026, 4:00 PM EDT
0.9000
-0.0310 (-3.33%)
After-hours: Jun 12, 2026, 7:28 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $5.03 million as of June 12, 2026. Its market cap has decreased by -82.48% in one year.
Market Cap
5.03M
Enterprise Value
6.02M
1-Year Change
-82.48%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $5.03M, a decrease of -99.47%. That is a compound annual growth rate of -89.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 5.03M | -66.40% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptevo Therapeutics | 5.58M |
| Processa Pharmaceuticals | 5.27M |
| TransCode Therapeutics | 5.24M |
| CollPlant Biotechnologies | 5.24M |
| XTL Biopharmaceuticals | 5.10M |
| Matinas BioPharma Holdings | 5.09M |
| Pulmatrix | 5.00M |
| Bio Green Med Solution | 4.99M |